Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?

This is the final published version of an editorial that has been published in its final definitive form by AME Publishing Company, 2019.

For re-use rights please refer to the publisher's terms and conditions.

Author(s): Smith-Jackson K, Marchbank KJ

Publication type: Editorial

Publication status: Published

Journal: Annals of Translational Medicine

Year: 2019

Volume: 6

Issue: Suppl 1

Print publication date: 01/11/2018

Online publication date: 01/11/2018

Acceptance date: 11/10/2018

ISSN (print): 2305-5839

ISSN (electronic): 2305-5847

Publisher: AME Publishing Company

URL: https://doi.org/10.21037/atm.2018.10.35

DOI: 10.21037/atm.2018.10.35

ePrints